The National Institute of Allergy and Infectious Diseases (NIAID) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS).
NIAID’s mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
NIAID has “intramural” (in-house) laboratories in Maryland and Montana, and funds research conducted by scientists at institutions in the United States and throughout the world. NIAID also works closely with partners in academia, industry, government, and non-governmental organizations in multifaceted and multidisciplinary efforts to address emerging health challenges such as the pandemic H1N1/09 virus.
SUBSCRIBE TO THE LATEST National Institute of Allergy and Infectious Disease (NIAID) RESEARCH UPDATES
National Institute of Allergy and Infectious Disease (NIAID) research articles from Innovation Toronto
- Universal Flu Vaccine in the Works – July 22, 2015
- Smartphone video microscope automates detection of parasites in blood – May 9, 2015
- Experimental Ebola Vaccine Safe, Prompts Immune Response
- Rapid and Durable Protection Against Ebola Virus With New Vaccine Regimens
- NIH and Italian Scientists Develop Nasal Test for Human Prion Disease
- Vivax malaria may be evolving around natural defense
- Researchers find Potential Novel Treatment for Influenza
- Rapid H.I.V. Home Test Wins Federal Approval
- Despite Safety Worries, Work on Deadly Flu to Be Released
- Better Way to Detect Food Allergies